You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.
UK-NOTPR-1010 | April 2022
Clinical trials are essential to determine whether new drugs are effective and tolerable when used to treat people. Carefully conducted clinical trials are performed in patients and human volunteers to provide answers to questions such as:
Does a treatment work?
Does it have benefits over other treatments?
Does it have side effects?
Deciding to participate in a clinical trial requires careful consideration. In most cases, the therapies investigated in clinical trials are not yet approved by regulatory agencies and the benefits and risks of taking the treatment are not completely known. However, regulatory agencies and ethics committees have approved the conduct of the clinical trial. By volunteering for a clinical trial, you are helping the medical community determine whether new treatments are effective and tolerable.
Lundbeck registers clinical trial protocols and discloses the results of clinical trials, regardless of outcome, in a publicly accessible clinical trial registry ClinicalTrials.gov. In addition, clinical trial protocols and results information, submitted by Lundbeck to the EudraCT database, is made publicly available by the European Medicines Agency (EMA) via its clinical trial registry.
Clinical trial reports will be accessible on the EMA’s page for clinical trial data in accordance with EMA POLICY/0070. Non-interventional studies may also be disclosed if, for example, they are considered to provide important safety data.
Lundbeck respects the privacy of the relationship between patients and healthcare professionals and is committed to ensuring that the process of scientific publication and clinical trial data sharing do not breach patient confidentiality.
Partnerships are a key pillar in our strategy to become leaders in brain health.
Our policy for scientific publications and responsible clinical data sharing.
Discover our projects and compounds in development.
UK-NOTPR-0546 | April 2022